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Rift Valley fever and lumpy skin disease are transboundary viral diseases endemic in Africa 
and some parts of the Middle East, but with increasing potential for global emergence. Wild 
ruminants, such as the African buffalo (Syncerus caffer), are thought to play a role in the 
epidemiology of these diseases. This study sought to expand the understanding of the role 
of buffalo in the maintenance of Rift Valley fever virus (RVFV) and lumpy skin disease virus 
(LSDV) by determining seroprevalence to these viruses during an inter-epidemic period. 
Buffaloes from the Kruger National Park (n = 138) and Hluhluwe-iMfolozi Park (n = 110) 
in South Africa were sampled and tested for immunoglobulin G (IgG) and neutralising 
antibodies against LSDV and RVFV using an indirect enzyme-linked immunosorbent assay 
(I-ELISA) and the serum neutralisation test (SNT). The I-ELISA for LSDV and RVFV detected 
IgG antibodies in 70 of 248 (28.2%) and 15 of 248 (6.1%) buffaloes, respectively. Using the SNT, 
LSDV and RVFV neutralising antibodies were found in 5 of 66 (7.6%) and 12 of 57 (21.1%), 
respectively, of samples tested. The RVFV I-ELISA and SNT results correlated well with 
previously reported results. Of the 12 SNT RVFV-positive sera, three (25.0%) had very high 
SNT titres of 1:640. Neutralising antibody titres of more than 1:80 were found in 80.0% of 
the positive sera tested. The LSDV SNT results did not correlate with results obtained by the 
I-ELISA and neutralising antibody titres detected were low, with the highest (1:20) recorded in 
only two buffaloes, whilst 11 buffaloes (4.4%) had evidence of co-infection with both viruses. 
Results obtained in this study complement other reports suggesting a role for buffaloes in the 
epidemiology of these diseases during inter-epidemic periods.
Introduction 
Rift Valley fever (RVF) and lumpy skin disease (LSD) are both economically important diseases, 
initially endemic to sub-Saharan Africa but which have expanded into North Africa and recently 
the Middle East (Israel, Saudi Arabia, Yemen and Oman) (Abraham & Zissman 1991; Fagbo 2002; 
Imam, Darwish & El-Karamany 1979). Both diseases have the potential for global emergence 
(Britch & Linthicum 2007; Tuppurainen & Oura 2012). 
Rift Valley fever is a mosquito-borne viral disease of domestic and wild ruminants characterised 
by necrotic hepatitis and haemorrhages, with often inapparent or mild infections in wild animals. 
The disease is caused by the Rift Valley fever virus (RVFV), a negative-sense, segmented single-
stranded RNA virus of the genus Phlebovirus in the family Bunyaviridae (Rice et al. 1980). 
Transmission is mainly by Aedes spp. mosquitoes and transovarial transmission via aedine eggs 
occurs (Linthicum et al. 1985). Many other mosquito genera, such as Anopheles, Culex and Mansonia 
transmit RVFV (Swanepoel & Coetzer 2004). Outbreaks of RVF in sub-Saharan Africa are usually 
associated with the emergence of large numbers of aedine mosquitoes following abnormally 
heavy rainfall with flooding. After virus amplification in vertebrates, mosquito species, such as 
Culex spp., act as secondary vectors to sustain the epidemic (Linthicum et al. 1985). In northern 
and western Africa, outbreaks have occurred independently of rainfall and transmission is 
mediated by river or dam breeding mosquitoes (Swanepoel & Coetzer 2004). The isolation of 
RVFV from mosquitoes and detection of RVFV-specific immunoglobulin G (IgG) in animal and 
human populations during inter-epidemic periods are indicative of RVFV activity (LaBeaud et al. 
2008; Linthicum et al. 1985; Rostal et al. 2010). 
The disease was first reported in 1931 in Kenya (Daubney, Hudson & Garnham 1931) and severe 
RVF outbreaks, serological evidence and/or virus isolation have since been recorded across 
sub-Saharan Africa (Olaleye et al. 1996; Ringot et al. 2004; Swanepoel & Coetzer 2004; Zeller 
et al. 1995). The disease has expanded geographically into Egypt (Imam et al. 1979), Madagascar 
(Morvan et al. 1992) and Saudi Arabia and Yemen on the Arabian Peninsula (Fagbo 2002). In 
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the past five years, recent outbreaks have occurred in 
Kenya and Madagascar (Andriamandimby et al. 2010; Bird 
et al. 2008). Major outbreaks in South Africa were recorded 
in 1950 and 1974–1975 and were preceded by wet climatic 
conditions that favoured an exponential rise in the vector 
population (Alexander 1951; Coetzer 1977). Between 2008 
and 2010, RVF outbreaks occurred every year in South Africa, 
affecting mainly four neighbouring provinces: Mpumalanga, 
Limpopo, Gauteng and North-West Provinces (Paweska et al. 
2010). 
The role of wildlife in the epidemiology of RVF remains 
unclear (Evans et al. 2008; Swanepoel & Coetzer 2004). The 
detection of neutralising antibodies to RVFV in African 
buffalo (Syncerus caffer), black rhino (Diceros bicornis), greater 
kudu (Tragelaphus strepsiceros), impala (Aepyceros melampus), 
African elephant (Loxodonta africana), kongoni (Alcelaphus 
buselaphus cokii) and waterbuck (Kobus ellipsiprymnus) in 
Kenya during an inter-epidemic period suggests that wild 
ruminants may serve as RVFV cycling hosts. The highest 
titres observed were in African buffaloes, in animals born 
during this period (Evans et al. 2008). Earlier experimental 
RVF infection of African buffalo in Kenya resulted in 
transient viraemia and abortion in one of the two gravid 
females (Davies & Karstad 1981). Abortions have also been 
reported in natural RVF outbreaks in buffaloes in South 
Africa (Paweska, Blumberg, Weyer, Kemp, Leman, Archer 
et al. 2008). 
Initial diagnosis of RVFV infection is based on abortions 
in livestock and fatalities especially in young animals. 
Acute febrile conditions in livestock workers may also be 
seen simultaneously (Swanepoel & Coetzer 2004). Various 
methods are used to detect acute or past RVFV infection in 
animals, humans and vectors (Bird et al. 2009; Njenga et al. 
2009; Swanepoel, Struthers & Erasmus 1986). Serological 
tests can be used to detect RVFV-specific immunoglobulin M 
(IgM) or IgG in animal or human sera (Davies 1982; Paweska 
et al. 2003; Paweska, Burt & Swanepoel 2005). Recently, a 
RVFV recombinant nucleocapsid protein (rNP) antigen 
indirect enzyme-linked immunosorbent assay (I-ELISA) 
was validated for humans, domestic ruminants and African 
buffaloes (Fafetine et al. 2007; Paweska, Jansen van Vuren & 
Swanepoel 2007; Paweska, Jansen van Vuren, Kemp, Buss, 
Bengis, Gakuya et al. 2008). 
Lumpy skin disease virus, a double-stranded DNA virus 
within the Poxviridae family is a member of the genus 
Capripoxvirus and closely related to goatpox and sheeppox 
viruses, the only other members of the genus (Buller et al. 
2005). Although cattle are the definitive hosts, LSDV has been 
associated with an outbreak of capripox infection in Kenyan 
sheep (Burdin & Prydie 1959) and LSDV-specific antibodies 
have been demonstrated in various wild ruminants, including 
blue wildebeest (Connochaetes taurinus), eland (Taurotragus 
oryx) giraffe (Giraffa camelopardalis), impala and greater kudu 
(Barnard 1997; Hedger & Hamblin 1983). Although these two 
studies reported negative results in a small African buffalo 
population, another study detected LSDV-specific antibodies 
in several buffaloes from a LSDV-endemic area in Kenya 
(Davies 1982). African buffaloes may thus play a role in the 
epidemiology of LSD. 
The LSDV survives for more than 30 days in skin lesions 
(Tuppurainen, Venter & Coetzer 2005; Weiss 1968) 
and infection is characterised by fever, multiple firm 
circumscribed skin nodules and necrotic plaques in the 
mucous membranes, mastitis, orchitis and swelling of the 
peripheral lymph nodes (Coetzer 2004). The disease was first 
reported in Zambia in the late-1930s (Weiss 1968) and reached 
South Africa by 1944 (Thomas, Robinson & Alexander 1945) 
affecting some eight million cattle (Backström 1945). It then 
spread throughout sub-Saharan Africa, characterised by 
periodic outbreaks (Davies 1991). Outside sub-Saharan 
Africa, LSD was first documented in Egypt (House et al. 
1990), followed by Israel (Abraham & Zissman 1991), with 
additional reports of serologically confirmed capripoxvirus 
infection in Saudi Arabia and Oman (capripoxvirus, not 
confirmed LSDV) (Greth et al. 1992; Kumar 2011). In South 
Africa, epidemics have persisted and more recent ones 
in 1989–1990 and 2000–2001 have been reported (Coetzer 
2004). Outbreaks also occurred in 2010 in the Eastern Cape, 
Mpumalanga, Limpopo, Free State, Gauteng, Western 
Cape and North-West Provinces of South Africa (World 
Organisation for Animal Health 2010). 
Saliva, infected skin lesions and milk have been implicated 
in the transmission of LSDV (Weiss 1968) and semen 
has experimentally been shown to transmit LSDV 
(Annandale et al. 2013). Direct transmission between animals 
is thought to be inefficient and mechanical transmission 
by blood-feeding arthropods has been suggested 
(Chihota et al. 2001). Recently, transmission of the virus by 
Ixodid ticks was also demonstrated (Lubinga et al. 2013; 
Tuppurainen et al. 2013).
Presumptive diagnosis is generally based on clinical signs, 
but various techniques are available for LSDV diagnosis 
(Awad et al. 2010; Binepal, Ongadi & Chepkwony 2001; 
Tuppurainen et al. 2005). The ELISA is most suited for 
screening large numbers of samples for evidence of past 
infection. Although the serum neutralisation test (SNT) is 
time consuming, lacks sensitivity and cannot discriminate 
between antibodies to the different capripoxviruses, it is a 
reliable serological test (Babiuk et al. 2009). 
Various ELISA protocols are available for LSDV diagnosis 
in cattle (Carn 1995; Heine et al. 1999; Paweska, Mortimer, 
Leman & Swanepoel 2005). A recently validated ELISA that 
detects antibodies to LSDV in cattle using an inactivated 
sheeppox virus has been used. It is easier to perform, less 
time consuming and does not require live virus and BSL-3 
facilities in LSD-free countries (Babiuk et al. 2009). However, 
a validated ELISA available for use in wildlife sera is lacking.
This study investigated the seroprevalence of LSDV and 
RVFV in stored sera of buffaloes obtained from the Kruger 
National Park (KNP) and Hluhluwe-iMfolozi Park (HiP), 
South Africa during an inter-epidemic period using an 
indirect ELISA (I-ELISA) and SNT. 
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Research method and design
Sample collection
Serum samples were collected between 2003 and 2004 from 
African buffaloes during a routine examination of animals 
in the KNP and HiP. Samples were collected from three 
areas in the KNP: Lower Sabie (twice sampled, once in 
2003 and 2004), Gudzani Dam and Satara, as well as from 
the HiP in the Kwazulu-Natal Province (Figure 1). These 
samples (Table 1) had been stored since 2003 at -20 °C at 
the Department of Veterinary Tropical Diseases, Faculty of 
Veterinary Science, University of Pretoria and were tested 
for antibodies to LSDV and RVFV. 
The KNP is the largest wildlife reserve (approximately 
20 000 km2) in South Africa. It has a length and breadth 
of about 320 km and 65 km respectively. It is bordered 
by Zimbabwe in the north and Mozambique in the east. 
The Lower Sabie area consists of the knobthorn savanna 
and Lebombo bushveld ecozones, whilst the surrounding 
vegetation at Satara is knobtorn and marula savanna on 
basalt soils; no specific vegetation description of the Gudzani 
Dam area could be found (South African National Parks 
[SANParks] n.d.; Venter & Gertenbach 1986). All three areas 
in the KNP experience a similar average annual rainfall 
of between 400 mm and 500 mm, mainly during summer 
(December, January and February) (SA Explorer 2011; Venter 
& Gertenbach 1986). As publicised on SANParks’ website for 
the KNP (http://www.sanparks.co.za/parks/kruger/), the 
Park supports more than 147 mammalian species, including 
about 2500 African buffaloes. 
The HiP is the third largest (about 900 km2) game reserve 
in South Africa. It is covered mainly by savanna grassland 
and the buffalo population (roughly about 3000) forms stable 
herds (Dora 2004). 
Laboratory tests 
Lumpy skin disease virus IgG indirect ELISA 
The I-ELISA used was carried out as described previously 
with minor modifications (Babiuk et al. 2009). The cut-off 
value for the I-ELISA was a standard deviation (s.d.) of +3 of 
the mean negative control. Each buffalo serum sample was 
tested twice to achieve quality control. For each plate, there 
were three replicates of the positive and negative controls 
and four replicates of the conjugate controls. The internal 
quality control (IQC) parameters upper control limits and 
lower control limits were derived from the mean ± 2 s.d. for 
replicates of each control (Paweska et al. 2003). Furthermore, 
the coefficient of variation of the positive control on each 
plate was monitored not to exceed 20%.
Rift Valley fever virus IgG indirect ELISA 
This I-ELISA protocol has been described previously and the 
kits were kindly provided by the Animal Research Council – 
Onderstepoort Veterinary Institute (Jansen van Vuren et al. 
2007). The mean optical density values were calculated into 
percentage positivity (PP) values for interpretation. Samples 
with PP values > 10 were regarded as positive. Lower PP 
values were interpreted to mean that fewer antibodies were 
detected in the samples.
The IQC procedure previously described was used with 
minor adjustments (Paweska, Jansen van Vuren et al. 2008). 
Each buffalo serum was tested twice and each plate had four 
replicates of each high-positive serum, negative serum and 
conjugate controls. 
Serum virus neutralisation test 
Selected positive and negative ELISA sera were tested 
by the SNT. The SNT procedures for both viruses were 
Source: Map drawn up by Estelle Mayhew
Key: Purple dots = indicate specific areas of sampling in the Kruger National Park.
FIGURE 1: Sites where samples were collected in the Kruger National Park and 
Hluhluwe-iMfolozi Park, South Africa. 
TABLE 1: Information on the buffalo sera used in this study.
Location Number of samples GPS coordinates
Month and year 
sampled
Lower Sabie (2003) 51 25°12’ S; 31°92’ E July 2003
Lower Sabie (2004) 41 25°12’ S; 31°92’ E September 2004
Gudzani Dam 25 24°37’ S; 31°93’ E August 2003
Satara 21 24°39’ S; 31°78’ E April 2003
Hluhluwe-iMfolozi 110 28°28’ S; 30°86’ E September 2004
Total 248 - -
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carried out following the standard operating procedures 
of the Department of Veterinary Tropical Diseases, Faculty 
Veterinary Science, University of Pretoria (Beard et al. 2010). 
Lumpy skin disease virus 
The procedure was carried out using 96-well, flat-bottomed 
cell culture microtitre plates according to the method 
described by Beard et al. (2010). Bovine dermis cells were 
used as culturing host and a working virus concentration 
of 100TCID50 was used. Plates were incubated at 37 °C in an 
atmosphere containing 5% CO2 for 14 days. The end point 
titre was determined from the last dilution where the virus or 
serum mixture inhibited cytopathic effect (CPE).
Rift Valley fever virus 
The same procedure for RVFV was used as with the LSDV 
SNT, but with minor modifications. Vero cells were used as 
culturing host. The plates were incubated at 37 °C in a humid 
atmosphere of 5% CO2 and observed daily for 4 days. The 
end point titre was determined from the last dilution where 
the virus or serum mixture inhibited CPE.
To ensure quality control of the SNT’s of both LSDV and 
RVFV, virus controls were carried out in duplicate on the 
same plate as some, but not all, of the samples. 
Ethical considerations
Samples were collected under supervision of a veterinarian 
during routine sampling of animals in the KNP and HiP. No 
animals were culled in the sampling process. All samples 
were transported to the BSL3 facility of the Agriculture 
Research Council’s Transboundary Animal Diseases 
Section where they were inactivated. Serum samples were 
then brought to the Department of Veterinary Tropical 
Diseases at the University of Pretoria for analysis in a BSL2 
laboratory.
Results
Indirect ELISA 
A total of 248 serum samples were each tested using the two 
different I-ELISAs. LSDV antibodies were detected in 28.2% 
(70 of 248) of samples. The highest prevalence was recorded 
in the HiP where 35.5% (39 of 110) were positive. From a total 
of 138 samples taken in the KNP, Lower Sabie (2004) had the 
highest percentage of LSDV I-ELISA IgG (10 of 41; 24.4%) 
followed by Satara with 5 positive samples (5 of 21; 23.8%). 
A total of 6.1% (15 of 248) of samples were positive using the 
RVF I-ELISA. The prevalence rate was highest for samples 
collected at Lower Sabie in 2003 (6 of 51; 11.8%), followed by 
Satara (2 of 21; 9.5%). A summary of these results is shown 
in Table 2. 
Serum virus neutralisation 
A subset of samples obtained from the KNP were tested for 
neutralising antibodies to LSDV (n = 66) and RVFV (n = 57). 
These included all ELISA positive samples, samples with 
borderline (PP) values and selected negative samples. Some 
samples could not be tested by the SNT because of insufficient 
serum. 
Of the 138 sera from the KNP tested by I-ELISA, 35 (25.4%) 
were tested for neutralising antibodies to LSDV and 38 
(27.5%) to RVFV by the SNT. Only five sera were positive 
for these antibodies to LSDV, three taken from Lower Sabie 
in 2003 and two from Gudzani Dam; nine sera were positive 
for antibodies to RVFV, the majority (88.9%; 8 of 9) of which 
were from Lower Sabie. None of the sera from Satara tested 
positive for LSDV (n = 7) or RVFV (n = 4) neutralising 
antibodies (Table 3). Of the samples from HiP that were 
tested for both viruses using the I-ELISA, 31 of 110 (28.2%) 
were tested for LSDV and 19 of 110 (17.3%) for RVFV using 
the SNT. None of these had neutralising antibodies to LSDV 
and three were positive for antibodies to RVFV (Table 3). 
Discussion 
Evidence of natural and experimental infections with RVFV 
and LSDV in wildlife has been documented (Davies & Karstad 
1981; Evans et al. 2008; Hedger & Hamblin 1983; Young, 
Basson & Weiss 1970). In this study, sera were collected from 
buffaloes during an inter-epidemic period in the KNP and 
HiP regions and the prevalence of antibodies to both LSDV 
and RVFV was obtained using I-ELISA protocols. Selected 
positive and negative sera from the ELISA were then tested 
using the SNT.
Based on RVFV IgG detection, a prevalence of 6.5% (9 of 
138) and 4.5% (5 of 110) in the KNP and HiP, respectively, 
were obtained in this study. Other studies similar to this one 
include those of Anderson and Rowe (1998), Barnard (1997), 
LaBeaud et al. (2011) and Wolhuter et al. (2009). In the earliest 
study, all 71 buffaloes (from the KNP) tested were negative. 
Another study from the KNP reported a seroprevalence 
of 57.6% (117 of 203), although the ELISA used was not 
described (Wolhuter et al. 2009). The most recent study 
TABLE 2: Indirect ELISA results for lumpy skin disease virus and Rift Valley fever virus.
Location Total number of 
samples
LSDV RVFV 
Positive samples Positive samples in %  Positive samples Positive samples in %
Lower Sabie (2003) 51 13 25.5 6 11.8
Lower Sabie (2004) 41 10 24.4 1 2.4
Gudzani Dam 25 3 12.0 1 4.0
Satara 21 5 23.8 2 9.5
Hluhluwe-iMfolozi Park 110 39 35.5 5 4.5
Total 248 70 28.2 15 6.1
LSDV, lumpy skin disease virus; RVFV, Rift Valley fever virus.
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reported 21.0% prevalence in 550 buffaloes tested from the 
KNP using only the haemagglutination inhibition (HAI) 
(LaBeaud et al. 2011). In the study performed in Zimbabwe, 
where both the IgG ELISA and a HAI protocol were used, 
34 of 514 (6.3%) buffaloes were positive (Anderson & Rowe 
1998). Other studies using buffalo sera either did not specify 
when samples were taken (epidemic or inter-epidemic 
period) or samples were from both periods (Evans et al. 2008; 
Paweska et al. 2007; Paweska, Jansen van Vuren, Kemp et al. 
2008; Paweska, Mortimer, Leman & Swanepoel 2005).
In the present study, 21.1% (12 of 57) of samples tested RVFV-
positive by the SNT. Results obtained by previous studies, 
where larger sample sizes were used, reported by Paweska 
et al. (2003) (5.8%; 54 of 928); Paweska, Jansen van Vuren, 
Kemp, Buss, Bengis, Gakuya et al. (2008) (7.5%; 77 of 1023) 
and Evans et al. (2008) (15.6%; 37 of 237), were lower than 
those obtained in this study. Results obtained by the study 
of Paweska, Mortimer, Leman and Swanepoel (2005) (20.5%; 
53 of 258) are similar to those of the present study. However, 
that study included samples obtained from an outbreak 
during 1997–1998 in East Africa, the proportion of which was 
not stated in the paper.
A high correlation between results obtained by the I-ELISA 
and the SNT (Pearson’s correlation coefficient) was evident 
in the studies of Evans et al. (2008) (R2 = 0.860) and Paweska, 
Jansen van Vuren, Kemp et al. (2008) (R2 = 0.882 Spearman 
test). A comparable high correlation was also obtained in 
this study between the SNT titres and the PP values from 
the I-ELISA. The Pearson’s correlation coefficient was 
R2 = 0.750. This study provides additional evidence that the 
rNP-based I-ELISA is a valuable diagnostic tool for RVFV 
seroprevalence studies in the African buffalo. 
From a total of 248 buffalo sera tested, 70 (28.2%) were 
positive for antibodies to LSDV (ELISA). In previous 
similar LSDV prevalence studies, African buffalo sera were 
collected between 1963 and 1996 (Barnard 1997; Davies 1982; 
Hamblin et al. 1990; Hedger & Hamblin 1983) and the SNT 
was mainly used to detect neutralising antibodies to LSDV 
(Barnard 1997); another combined the SNT with the indirect 
fluorescent antibody test (IFAT) (Davies 1982). In the present 
study, the LSDV SNT detected neutralising antibodies in 5 
of 66 (7.6%) samples, some of them with low titres of, for 
example, 1:20. In the study by Barnard (1997), 15 buffalo 
samples from the KNP were tested and although antibodies 
to LSDV were detected in wildebeest, eland, springbok 
and impala, no antibodies to LSDV could be detected in 
buffaloes. The small number of buffaloes tested was probably 
not representative of the potentially infected buffaloes in 
the KNP. Davies (1982) detected neutralising antibodies in 
buffalo sera collected during epidemic and inter-epidemic 
periods in Kenya, Tanzania and Uganda. He indicated that a 
subset of the IFAT positive samples (150 of 254; 59.1%) were 
positive by SNT without giving the exact number. Another 
study, with a much larger and more diverse sample size than 
the present study, tested more wild ruminant species (n = 8) 
from different game areas in Tanzania (Hamblin et al. 1990). 
Although all the 370 buffalo sera tested were negative for 
LSDV neutralising antibodies, information on disease activity 
at the time of sampling was lacking (Hamblin et al. 1990). The 
largest LSDV prevalence study in buffalo tested samples 
collected between 1963 and 1982 from 11 sub-Saharan African 
countries and all the samples (1413) were negative for LSDV 
neutralising antibodies (Hedger & Hamblin 1983). 
The SNT is not very sensitive in detecting LSDV neutralising 
antibodies because of the predominantly cell-mediated 
immune response to LSDV infection (Babiuk et al. 2009). 
Additionally, LSDV does not easily grow in cell cultures, 
which makes the SNT difficult to perform. However, the use 
of bovine dermis cells, a primary cell culture, in this study 
may have contributed to the sensitivity of the SNT. These 
cells have previously been used to detect LSDV in blood 
and semen of experimentally infected bulls (Bagla et al. 2006; 
Tuppurainen et al. 2005). 
Earlier researchers using a cloned capripoxvirus structural 
protein (P32) antigen showed that the ELISA was more 
sensitive than the SNT in detecting LSDV antibodies in 
bovine sera (Carn et al. 1994). The current study on buffalo 
sera had a fairly large sample size and the I-ELISA detected 
a high percentage (28.2%) of positive samples. However, the 
results obtained by the SNT, although it is the gold standard, 
did not compare well with results obtained by the I-ELISA 
used in this study. A purified, heat-inactivated, Nigerian 
sheeppox virus as coating antigen was used (Babiuk et al. 
2009) in this I-ELISA and was not specifically validated for 
wildlife sera.
Difficulties encountered with development and evaluation 
of serodiagnostic tests for capripoxviruses have been in 
obtaining sufficiently large numbers of well-characterised 
TABLE 3: Serum virus neutralisation test results for lumpy skin disease virus and Rift Valley fever virus.
Location LSDV RVFV
Total number of 
samples†
Positive 
samples
Positive 
samples in %
Total number of 
samples‡
Positive 
samples
Positive 
samples in %
Lower Sabie (2003) 14 3 21.4 16 7 53.9
Lower Sabie (2004) 10 0 0.0 11 1 9.1
Gudzani Dam 4 2 50.0 7 1 14.3
Satara 7 0 0.0 4 0 0.0
Hluhluwe-iMfolozi Park 31 0 0.0 19 3 15.8
Total 66 5 7.6 57 12 21.1
LSDV, lumpy skin disease virus; RVFV, Rift Valley fever virus; ELISA, enzyme-linked immunosorbent assay.
†, Nine samples not tested due to insufficient sera – all were ELISA positive.
‡, Three samples not tested due to insufficient sera – one ELISA positive and two ELISA negatives.
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sera from different host species (e.g. sheep, goats, cattle 
and buffalo) to facilitate validation (Timothy Bowden pers. 
comm., 03 June 2011). There are also a large number of host 
(including breed, age, sex, previous infection or vaccination 
history, quality of sera etc.) and laboratory sheeppox virus 
factors that might affect the performance characteristics 
(diagnostic sensitivity and diagnostic specificity) of any 
antibody-detecting ELISA. Determining the true exposure 
status of naturally infected animals is therefore often difficult. 
It is therefore not unusual to obtain a large percentage of 
seropositive animals, as in this study, using the ELISA.
The high percentage of LSDV-positive antibody results 
obtained in this study is, however, a concern. Results are 
in contrast with other published results, as well as results 
obtained with the SNT for antibodies against LSDV. Samples 
were obtained from the field and the possibility that the 
results by the I-ELISA are false positives cannot be excluded. 
A validated LSDV-specific ELISA, although difficult to 
establish, should be used for testing buffalo and other 
wildlife sera. 
Conclusion
This study provides data indicating previous infection by 
LSDV and RVFV in an African buffalo population in the 
KNP and HiP during an inter-epidemic period. The role of 
buffaloes in the epidemiology of these diseases is, however, 
still not clear. From the results obtained, both the SNT 
and ELISA tests used for RVFV are sensitive and provide 
reproducible results. However, further studies are required 
to evaluate the performance characteristics (sensitivity and 
especially the specificity) of the I-ELISA assay for the detection 
of antibodies against LSDV in African buffalo serum in order 
to detect the true prevalence of LSDV antibodies in buffalo. 
In particular, a large number of known LSD-negative serum 
samples should be tested using the I-ELISA.
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